HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boiron Posts Big Sales Gain As It Benefits From Easy Comp

Executive Summary

French homeopathy specialist Boiron reported sales up by 60% in Q1 as the business returned to growth following the end of COVID-19 social restrictions.

You may also be interested in...



Boiron Moves Into Personalized Beauty As Sales Continue To Slide

France's Boiron has acquired cosmetics player ABBI, which uses artificial intelligence to offer consumers personalized beauty products. The move comes as Boiron reported 2021 sales down double-digits as homeopathy sales in its home market continue to decline.

EU Q1 Sales Round-Up: Karo Pharma, Boiron And Ipsen

Consumer health first-quarter results round-up featuring Karo Pharma, Boiron and Ipsen.

France's Boiron Diversifies Into Probiotics To Arrest Sales Decline

Homeopathy specialist Boiron its diversifying its offering into the increasingly popular probiotics segment with launches underway in France, Italy and Spain, as well as Eastern Europe.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel